212 related articles for article (PubMed ID: 20448372)
1. Non-FDG PET in the practice of oncology.
Caroli P; Nanni C; Rubello D; Alavi A; Fanti S
Indian J Cancer; 2010; 47(2):120-5. PubMed ID: 20448372
[TBL] [Abstract][Full Text] [Related]
2. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
3. Non FDG PET.
Nanni C; Fantini L; Nicolini S; Fanti S
Clin Radiol; 2010 Jul; 65(7):536-48. PubMed ID: 20541653
[TBL] [Abstract][Full Text] [Related]
4. New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
Gulyás B; Halldin C
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):173-90. PubMed ID: 22617239
[TBL] [Abstract][Full Text] [Related]
5. [Tracers in oncology - preclinical and clinical evaluation].
Krause BJ; Schwarzenböck S; Schwaiger M
Nuklearmedizin; 2010; 49 Suppl 1():S41-5. PubMed ID: 21152689
[TBL] [Abstract][Full Text] [Related]
6. Current status of PET imaging of neuroendocrine tumours ([18F]FDOPA, [68Ga]tracers, [11C]/[18F]-HTP).
Ambrosini V; Morigi JJ; Nanni C; Castellucci P; Fanti S
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):58-69. PubMed ID: 25677589
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of positron emission tomographic tracers for imaging of papillomavirus-induced tumors in rabbits.
Probst S; Wiehr S; Mantlik F; Schmidt H; Kolb A; Münch P; Delcuratolo M; Stubenrauch F; Pichler BJ; Iftner T
Mol Imaging; 2014; 13():. PubMed ID: 24622808
[TBL] [Abstract][Full Text] [Related]
8. 32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016.
Langsteger W; Rezaee A; Loidl W; Geinitz HS; Fitz F; Steinmair M; Broinger G; Pallwien-Prettner L; Beheshti M; Imamovic L; Beheshti M; Rendl G; Hackl D; Tsybrovsky O; Steinmair M; Emmanuel K; Moinfar F; Pirich C; Langsteger W; Bytyqi A; Karanikas G; Mayerhöfer M; Koperek O; Niederle B; Hartenbach M; Beyer T; Herrmann K; Czernin J; Rausch I; Rust P; DiFranco MD; Lassen M; Stadlbauer A; Mayerhöfer ME; Hartenbach M; Hacker M; Beyer T; Binzel K; Magnussen R; Wei W; Knopp MU; Flanigan DC; Kaeding C; Knopp MV; Leisser A; Nejabat M; Hartenbach M; Kramer G; Krainer M; Hacker M; Haug A; Lehnert W; Schmidt K; Kimiaei S; Bronzel M; Kluge A; Wright CL; Binzel K; Zhang J; Wuthrick E; Maniawski P; Knopp MV; Blaickner M; Rados E; Huber A; Dulovits M; Kulkarni H; Wiessalla S; Schuchardt C; Baum RP; Knäusl B; Georg D; Bauer M; Wulkersdorfer B; Wadsak W; Philippe C; Haslacher H; Zeitlinger M; Langer O; Bauer M; Feldmann M; Karch R; Wadsak W; Zeitlinger M; Koepp MJ; Asselin MC; Pataraia E; Langer O; Zeilinger M; Philippe C; Dumanic M; Pichler F; Pilz J; Hacker M; Wadsak W; Mitterhauser M; Nics L; Steiner B; Hacker M; Mitterhauser M; Wadsak W; Traxl A; Wanek T; Kryeziu K; Mairinger S; Stanek J; Berger W; Kuntner C; Langer O; Mairinger S; Wanek T; Traxl A; Krohn M; Stanek J; Filip T; Sauberer M; Kuntner C; Pahnke J; Langer O; Svatunek D; Denk C; Wilkovitsch M; Wanek T; Filip T; Kuntner-Hannes C; Fröhlich J; Mikula H; Denk C; Svatunek D; Wanek T; Mairinger S; Stanek J; Filip T; Fröhlich J; Mikula H; Kuntner-Hannes C; Balber T; Singer J; Fazekas J; Rami-Mark C; Berroterán-Infante N; Jensen-Jarolim E; Wadsak W; Hacker M; Viernstein H; Mitterhauser M; Denk C; Svatunek D; Sohr B; Mikula H; Fröhlich J; Wanek T; Kuntner-Hannes C; Filip T; Pfaff S; Philippe C; Mitterhauser M; Hartenbach M; Hacker M; Wadsak W; Wanek T; Halilbasic E; Visentin M; Mairinger S; Stieger B; Kuntner C; Trauner M; Langer O; Lam P; Aistleitner M; Eichinger R; Artner C; Eidherr H; Vraka C; Haug A; Mitterhauser M; Nics L; Hartenbach M; Hacker M; Wadsak W; Kvaternik H; Müller R; Hausberger D; Zink C; Aigner RM; Cossío U; Asensio M; Montes A; Akhtar S; Te Welscher Y; van Nostrum R; Gómez-Vallejo V; Llop J; VandeVyver F; Barclay T; Lippens N; Troch M; Hehenwarter L; Egger B; Holzmannhofer J; Rodrigues-Radischat M; Pirich C; Pötsch N; Rausch I; Wilhelm D; Weber M; Furtner J; Karanikas G; Wöhrer A; Mitterhauser M; Hacker M; Traub-Weidinger T; Cassou-Mounat T; Balogova S; Nataf V; Calzada M; Huchet V; Kerrou K; Devaux JY; Mohty M; Garderet L; Talbot JN; Stanzel S; Pregartner G; Schwarz T; Bjelic-Radisic V; Liegl-Atzwanger B; Aigner R; Stanzel S; Quehenberger F; Aigner RM; Marković AK; Janković M; Jerković VM; Paskaš M; Pupić G; Džodić R; Popović D; Fornito MC; Familiari D; Koranda P; Polzerová H; Metelková I; Henzlová L; Formánek R; Buriánková E; Kamínek M; Thomson WH; Lewis C; Thomson WH; O'Brien J; James G; Notghi A; Huber H; Stelzmüller I; Wunn R; Mandl M; Fellner F; Lamprecht B; Gabriel M; Fornito MC; Leonardi G; Thomson WH; O'Brien J; James G; Hudzietzová J; Sabol J; Fülöp M
EJNMMI Res; 2016 Apr; 6(Suppl 1):32. PubMed ID: 27090254
[TBL] [Abstract][Full Text] [Related]
9. PET with radiolabeled aminoacid.
Crippa F; Alessi A; Serafini GL
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):151-62. PubMed ID: 22617237
[TBL] [Abstract][Full Text] [Related]
10. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
11. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
12. The role of new PET tracers for lung cancer.
Szyszko TA; Yip C; Szlosarek P; Goh V; Cook GJ
Lung Cancer; 2016 Apr; 94():7-14. PubMed ID: 26973200
[TBL] [Abstract][Full Text] [Related]
13. From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology.
Kubota K
Ann Nucl Med; 2001 Dec; 15(6):471-86. PubMed ID: 11831394
[TBL] [Abstract][Full Text] [Related]
14. Is 18F-3'-fluoro-3'-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer?
Cobben DC; Elsinga PH; Hoekstra HJ; Suurmeijer AJ; Vaalburg W; Maas B; Jager PL; Groen HM
J Nucl Med; 2004 Oct; 45(10):1677-82. PubMed ID: 15471832
[TBL] [Abstract][Full Text] [Related]
15. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
[TBL] [Abstract][Full Text] [Related]
16. Molecular imaging (PET) of brain tumors.
Basu S; Alavi A
Neuroimaging Clin N Am; 2009 Nov; 19(4):625-46. PubMed ID: 19959009
[TBL] [Abstract][Full Text] [Related]
17. 3'-Deoxy-3'-18F-fluorothymidine as a proliferation imaging tracer for diagnosis of lung tumors: comparison with 2-deoxy-2-18f-fluoro-D-glucose.
Yamamoto Y; Nishiyama Y; Ishikawa S; Gotoh M; Bandoh S; Kanaji N; Asakura M; Ohkawa M
J Comput Assist Tomogr; 2008; 32(3):432-7. PubMed ID: 18520552
[TBL] [Abstract][Full Text] [Related]
18. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
[TBL] [Abstract][Full Text] [Related]
19. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
